Chemo Brain- Nothing Forgettable About It ( advocates challenging doctors and volu...)

(Date:5/16/2008)...e/ -- ExamForce announced today the,hiring of John...es Manager.,Mongeon formerly headed up the Governm... oversaw government sales and marketing initiative...y certifications in the IT,industry., Mongeon, a ...C)2,Americas to spend more time with his two-year ...

(Date:5/16/2008)...7 Comprehensive Income increased 42% to $9.7 milli..., - 2007 Gross Margin of 76%, - Product Sales Ba... million from $2.4 million as of December 31, 2...irstCall/ -- Huiheng,Medical, Inc. ("Huiheng" or t...based leader in the development, sales and support...

(Date:5/16/2008)...ree for at least a year or two, , , F...et cells help people with type 1 diabetes live ins...o provide longer-term improved metabolic control e..., researchers report. , Using continuous glucos...ity of Miami Miller School of Medicine found that ...

(Date:5/16/2008)...ire-USNewswire/ -- Karin Weisburgh,senior researc...her of,Consumer Reports magazine, was named Westch... Yonkers headquarters today., Ms. Weisburgh commu...n,the winter and rides in shirt sleeves in the sum...er Ridge in New Rochelle, down Mill Road in,Eastch...

[0] ExamForce Hires Former (ISC)2 Americas Leader to Head Corporate and Government Sales Efforts [0] Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 [1] Islet Cell Transplants Aid Type 1 Diabetics [0] Westchester Cycle Club Awards Consumers Union Staffer Karin Weisburgh Commuter of the Year

...ores Cancer Center at the University of California...uming 1000 International Units (IU) of vitamin D3 ... breast cancer and ovarian cancer. "For example, ...merican women in their lifetime. Early detection u...

...sent governor f Vermont has come up with a new str... one third are still uninsured // because they can...very individual will be assigned to a primary clin...er health. The governor's plan segregates the 60...

...as been passed by the Food and Drug Administration...resent in the food // had to be mentioned in the l... come under common food allergens are milk, eggs, ...nuts, soybeans and peanuts. This law will be effe...

... admitted to UK hospitals every day suffering from...ple a day end up in hospital because of binge drin...ls every day suffering from the effects of binge d...more than 51,000 were admitted to hospital in 2004...

Other Medicine News:Health News:Vitamin D Reduces Chances of Colon, Breast And Ovarian Cancers by 50% 2 Health News:Vermont Governor steps in with a new health insurance plan. 2 Health News:UK children getting high on binge drinking 2

Vitamin D Reduces Chances of Colon, Breast And Ovarian Cancers by 50%Vermont Governor steps in with a new health insurance plan.Look For Food Allergens On The Product Label.UK children getting high on binge drinking

(Date:5/16/2008)... MONTVALE, N.J., May 16 /PRNewswire-FirstCall/ ...oday announced progress with several key developme...ment community. The Company,reported new clinical ...trating the compound,s CNS activity in humans. In ...he lead development candidate from its,5-HT6 antag...

(Date:5/16/2008)... Nektar,s Technology Enables First-Ever PEGylation...trated Therapeutic Activity, SAN CARLOS, Calif., ...cs (Nasdaq: NKTR ) announced initial results toda...notecan. The data shows significant,anti-tumor act...e study,also demonstrates that Nektar,s small mole...

(Date:5/15/2008)... - Trial Results Confirm Efficacy for Population M...ILLE, Calif., May 16 /-,Bay...aceuticals, Inc.,(Nasdaq: ONXX ) today announced ...improved overall survival by 47.3 percent (HR=0.68...egion with advanced,hepatocellular carcinoma (HCC)...

(Date:5/15/2008)... - Safety and Efficacy Clinical Data from Prostate... Cancers -, - Company to Hold Investor Event ...N FRANCISCO, Calif., May 15 /PRNewswire-FirstCall/..., a biopharmaceutical company focused,on oncology,...a from three,clinical trials of picoplatin, in var...

Breaking Medicine Technology:Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 2 Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 3 Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 4 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5 Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6 Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2 Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3 Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4 Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5 The structural basis of familial hypertrophic cardiomyopathy is revealed 5960 1 UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 1 UC San Diego Engineering Honor Society wins most outstanding chapter award 1161 2 Drugs Can Ease Juvenile Rheumatoid Arthritis 5958 1 Drugs Can Ease Juvenile Rheumatoid Arthritis 5958 2 Pill Poses Little Cervical Cancer Risk 5956 1 Pill Poses Little Cervical Cancer Risk 5956 2 Pill Poses Little Cervical Cancer Risk 5956 3

[0] Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day [0] Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings [0] Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study [0] Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting

...cal Oncology publishes first clinical study of,HGS...e-FirstCall/ -- Human,Genome Sciences, Inc. today ...ntinues to emerge demonstrating that its TRAIL rec...TR2 (lexatumumab), have,significant potential for ..., "We believe that HGS-ETR1 and HGS-ETR2 could off...

...USINESS WIRE)--Apr 30, 2007 - Cobalis Corp. (OTC,B...cializing in,anti-allergy medications, today annou...act research organization that it would need,more ...nto a single,database before un-blinding and condu...e top-line results for Cobalis, twin pivotal,Phase...

Other Medicine Technology:Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 2 Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 3 Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 4 Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers 5 Cobalis Expects to Report Phase III Top-Line Results in May 2

Human Genome Sciences Reports Growing Evidence That Its TRAIL,Receptor Antibodies Have Significant Potential in the Treatment of,a Broad Range of Cancers Cobalis Expects to Report Phase III Top-Line Results in May

...t saw to remove a cast from an arm or leg can ofte...s are cut or burned by the cast saw blade. GORE DE...onals to remove any cast with confidence. This inn...rotection against cuts and burns from the cast saw...

...replacement of chordae tendineae is a critical, ex... been used successfully in chordae tendineae proce...bsorbable monofilament suture available with a nee...e suture also is provided with thin ePTFE pledgets...

... bypass grafting or creation of a vascular access,...the utmost importance in many vascular procedures....igh-precision tunneling instrument. The unique hol...sting or kinking for more accurate graft placement...

...g; Stretch Vascular Grafts have met the challenges...ized for exceptional performance and quality, they...worldwide. These grafts require no preclotting, re...nsure utmost thrombectomy safety. The GORE-TEX®...

Medicine Products:

GORE PROCEL® De-flex Protective Strip GORE-TEX Suture for Chordae Tendineae GORE Tunneler-Standard Curve Access GORE-TEX® Stretch Vascular Grafts-Standard Wall with Removable Rings

( advocates challenging doctors and volu...)Chemo Brain- Nothing Forgettable About It,Health